AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUREN PHARMACEUTICALS LTD

12.440

+0.6405.42%

Volume:606.89K

Turnover:7.55M

Market Cap:1.56B

PE:11.45

High:12.790

Open:11.740

Low:11.670

Close:11.800

Loading ...

Overview Company News Filings

Neuren Pharmaceuticals Ltd-Update - Notification of Buy-Back - Neu

THOMSON REUTERS

How your 20 most-tipped ASX stocks performed in 2024

Neuren Pharmaceuticals Ltd-Update - Notification of Buy-Back - Neu

THOMSON REUTERS

Neuren Pharmaceuticals Ltd-Update - Notification of Buy-Back - Neu

THOMSON REUTERS

Buy Hold Sell: 5 dogs of 2024 tipped to rebound in 2025

Investing in a World of Options and Asymmetry

The 8.7% return this week takes Neuren Pharmaceuticals' (ASX:NEU) shareholders five-year gains to 482%

Simply Wall St.

Here are the top 10 ASX 200 shares today

Neuren Pharmaceuticals Ltd-Update - Notification of Buy-Back - Neu

THOMSON REUTERS

My 2 best ASX growth shares to buy in November

18 stocks backed by a fund that returned 42% in 12 months

New Forecasts: Here's What Analysts Think The Future Holds For Neuren Pharmaceuticals Limited (ASX:NEU)

Simply Wall St.

Here are the best-performing ASX 200 shares since the US election result

Here are the top 10 ASX 200 shares today

Neuren Pharmaceuticals to Launch AU$50 Million Share Buyback; Shares Up 6%

MT Newswires Live

3 ASX healthcare shares going gangbusters on Thursday

BUZZ-Australia's Neuren Pharma hits over 3-month high on $32 mln share buyback

BRIEF-Neuren Pharmaceuticals Announces A$50M On-Market Share Buy-Back Program

Neuren Pharmaceuticals Ltd - Announces a$50M on-Market Share Buy-Back Program

THOMSON REUTERS

Why ANZ, Block, Neuren, and Pilbara Minerals shares are pushing higher today

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NEU.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NEU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","market":"AU","secType":"STK","nameCN":"NEUREN PHARMACEUTICALS LTD","latestPrice":12.44,"timestamp":1746166320000,"preClose":11.8,"halted":0,"volume":606889,"delay":0,"nameEN":"NEUREN PHARMACEUTICALS LTD","floatShares":109162108,"shares":125428851,"eps":1.086099,"marketStatus":"Market Closed","change":0.64,"latestTime":"05-02 16:12:00 AEST","open":11.74,"high":12.79,"low":11.67,"amount":7554578,"amplitude":0.094915,"askPrice":12.65,"askSize":17500,"bidPrice":12.38,"bidSize":80,"shortable":3,"etf":0,"ttmEps":1.086099,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746403200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":11.8,"openAndCloseTimeList":[[1746144000000,1746165600000]],"volumeRatio":1.085665944582007,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","floatShares":109162108,"roa":"34.05%","roe":"49.92%","lyrEps":1.111713,"volumeRatio":1.085665944582007,"shares":125428851,"dividePrice":0,"high":12.79,"amplitude":0.094915,"preClose":11.8,"low":11.67,"week52Low":8.61,"pbRate":"4.29","psRate":"7.20","week52High":24,"institutionHeld":0,"latestPrice":12.44,"committee":-0.990899,"eps":1.086099,"divideRate":0,"volume":606889,"delay":0,"ttmEps":1.086099,"open":11.74,"prevYearClose":12.5,"prevWeekClose":11.34,"prevMonthClose":11.66,"prevQuarterClose":11.93,"fiveDayClose":11.34,"twentyDayClose":11.35,"sixtyDayClose":13.18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEU.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490027051","title":"Neuren Pharmaceuticals Ltd-Update - Notification of Buy-Back - Neu","url":"https://stock-news.laohu8.com/highlight/detail?id=2490027051","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490027051?lang=en_us&edition=fundamental","pubTime":"2024-12-11 06:35","pubTimestamp":1733870145,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUE2SHH3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NEU.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2490162024","title":"How your 20 most-tipped ASX stocks performed in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2490162024","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490162024?lang=en_us&edition=fundamental","pubTime":"2024-12-11 06:30","pubTimestamp":1733869803,"startTime":"0","endTime":"0","summary":"2024 has been a remarkable period for Australian investors, defying expectations and setting new benchmarks. The S&P/ASX 200 achieved seven monthly record closes  – the most since 2007 – while Commonwealth Bank soared well beyond analyst predictions, trading comfortably above $150 despite consensus target prices around $90. Meanwhile, tech stocks such as Wisetech, Life360, and Technology One reached unprecedented heights.At the start of the year, almost 5,000 Livewire and Market Index readers participated in the Outlook Series Survey, and  we identified your 20 top-tipped ASX stocks. As with any forecast, the results were a mixed bag – some picks flourished while others floundered. Yet, the survey provides fascinating insights into market expectations and actual performance.Please note: We are sharing information from the Livewire and Market Index readerships by publishing this list. We hope it inspires ideas for your investment research. This information is not, nor is it intended to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/how-your-20-most-tipped-asx-stocks-performed-in-2024","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/how-your-20-most-tipped-asx-stocks-performed-in-2024","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7103","TLX.AU","BK7007","BK7508","BK7067","BK7501","NEU.AU","BK7094","CSL.AU","BK7096","BK7511","SIG.AU","RMD.AU","PME.AU"],"gpt_icon":0},{"id":"2490308960","title":"Neuren Pharmaceuticals Ltd-Update - Notification of Buy-Back - Neu","url":"https://stock-news.laohu8.com/highlight/detail?id=2490308960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490308960?lang=en_us&edition=fundamental","pubTime":"2024-12-10 06:12","pubTimestamp":1733782339,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nTUE3Z0WLP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","NEU.AU"],"gpt_icon":0},{"id":"2490875799","title":"Neuren Pharmaceuticals Ltd-Update - Notification of Buy-Back - Neu","url":"https://stock-news.laohu8.com/highlight/detail?id=2490875799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490875799?lang=en_us&edition=fundamental","pubTime":"2024-12-09 05:36","pubTimestamp":1733693795,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241208:nTUE660MFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","NEU.AU"],"gpt_icon":0},{"id":"2489491958","title":"Buy Hold Sell: 5 dogs of 2024 tipped to rebound in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2489491958","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489491958?lang=en_us&edition=fundamental","pubTime":"2024-12-06 04:00","pubTimestamp":1733428823,"startTime":"0","endTime":"0","summary":"The end of the year naturally brings a time of reflection. We collectively get a moment to breathe and reflect on our family, friends, and careers.For those who play Mr. Market's game, we also invariably run a critical eye over our portfolios and make some decisions on what to keep and what to turf out like four-day-old Christmas leftovers.Shedding the duds also means hunting for new opportunities and while piling into the top 10 best performers from this year is always tempting, there are probably some equal, if not better opportunities to be had in the downtrodden.With that in mind, this latest episode of Buy Hold Sell sees Henry Jennings from Marcus Today and Hugh Dive from Atlas Funds Management rummaging through the equity bargain bin like someone who camps out for the Boxing Day sales. Will they find any unloved gems?As a bonus, Henry and Hugh each nominate a stock they think is set to get going in 2025.Note: This episode was recorded on Wednesday 4 December 2024. You can watch t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/buy-hold-sell-5-dogs-of-2024-tipped-to-rebound-in-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/buy-hold-sell-5-dogs-of-2024-tipped-to-rebound-in-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BUY","BUY.AU","BK7070","BK7509","BK7142","WEB.AU","BK7083","HOLD","MIN.AU","BK7095","PDN.AU","VEA.AU","BK7065","BK7507","BK7096","NEU.AU","BK7504","BK7508"],"gpt_icon":0},{"id":"2489432650","title":"Investing in a World of Options and Asymmetry","url":"https://stock-news.laohu8.com/highlight/detail?id=2489432650","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489432650?lang=en_us&edition=fundamental","pubTime":"2024-12-05 20:01","pubTimestamp":1733400077,"startTime":"0","endTime":"0","summary":"“The secret to wealth is finding the asymmetric payoff—small risk, big reward” Nassim Taleb. When this writer first set about a career in finance we were tasked with uncovering how much each ASX energy company was worth, with little more direction than a basic understanding of discounted cash flows and net present values. The task was easy enough; to develop an asset by asset model that delivered a valuation per share, but how do you consider:. Specifically when it comes to oil and gas we were utilising it in the pricing of exploration plays. How does this work?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/investing-in-a-world-of-options-and-asymmetry","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/investing-in-a-world-of-options-and-asymmetry","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["IE00BVYPNV92.GBP","LU0472753341.HKD","CU6.AU","MTR","IE00B3CCJ633.GBP","LU0511384066.AUD","BK4211","AS","BK7503","MIN","NEU.AU","IE00B3PB1722.GBP","LU2506952410.USD","LU2506952337.HKD","LU2477742899.HKD","ASB.AU","TLX.AU","IE00B2PGVK34.USD","OPC.AU","ORA","WTC.AU","NEU","TLX","BK7053","BK4133","MIN.AU","LU0289739343.SGD","AFL","TAM.AU","LU0689626769.HKD","BK7050","BK7502","MTR.AU","PET.AU","LU0124676726.USD","IMR.AU","AFL.AU","BK7096","BK4162","IE00BDGV0183.EUR","PET","BK7067","BK7507","BK7508","ORA.AU","LU0289961442.SGD","BK7504","ASB","BOT.AU","BK7115"],"gpt_icon":0},{"id":"2488318499","title":"The 8.7% return this week takes Neuren Pharmaceuticals' (ASX:NEU) shareholders five-year gains to 482%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488318499","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488318499?lang=en_us&edition=fundamental","pubTime":"2024-12-04 05:39","pubTimestamp":1733261971,"startTime":"0","endTime":"0","summary":"We think all investors should try to buy and hold high quality multi-year winners. While the best companies are hard to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/the-87-return-this-week-takes-neuren-pharmaceuticals-asxneu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4109","BK7096","BK7508","NEU.AU","NEU"],"gpt_icon":0},{"id":"2488952084","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2488952084","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488952084?lang=en_us&edition=fundamental","pubTime":"2024-12-03 13:57","pubTimestamp":1733205420,"startTime":"0","endTime":"0","summary":"It was another fantastic day for the S&P/ASX 200 Index (ASX: XJO) this Tuesday, with the index hitting its latest new all-time high. The ASX 200 added 0.56% by the close of today's session, leaving th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/12/03/here-are-the-top-10-asx-200-shares-today-545/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7062","SQ2.AU","PME.AU","BK7033","XJO.AU","MFG.AU","MTS.AU","BK7096","NEU.AU","BK7078","BK7094","SGR.AU","BK7028","NWL.AU","360.AU","LNW.AU","BK7016","BK7158","BK7508","PNI.AU"],"gpt_icon":0},{"id":"2488981201","title":"Neuren Pharmaceuticals Ltd-Update - Notification of Buy-Back - Neu","url":"https://stock-news.laohu8.com/highlight/detail?id=2488981201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488981201?lang=en_us&edition=fundamental","pubTime":"2024-12-03 06:14","pubTimestamp":1733177652,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nTUE7MVBD0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NEU.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2485761473","title":"My 2 best ASX growth shares to buy in November","url":"https://stock-news.laohu8.com/highlight/detail?id=2485761473","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485761473?lang=en_us&edition=fundamental","pubTime":"2024-11-22 07:54","pubTimestamp":1732233284,"startTime":"0","endTime":"0","summary":"The intrigue of ASX growth shares enthrals many investors. Often, stocks in this category catch headlines and see their shares bid up to high prices.  Qualifying these companies for 'growth' is the gr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/22/my-2-best-asx-growth-shares-to-buy-in-november/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["NEU.AU","BK7096","FLT.AU","BK7508","BK7070"],"gpt_icon":0},{"id":"2484798937","title":"18 stocks backed by a fund that returned 42% in 12 months","url":"https://stock-news.laohu8.com/highlight/detail?id=2484798937","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484798937?lang=en_us&edition=fundamental","pubTime":"2024-11-19 10:20","pubTimestamp":1731982807,"startTime":"0","endTime":"0","summary":"Small-cap stocks have experienced a renaissance over the last 12 months, with the Small Ordinaries Index returning 26.55% to the end of October. Investors have their sights on a continued small-cap recovery, as the economic storm clouds that have plagued the index finally appear to have cleared after several years of large-cap outperformance.According to consensus estimates, economists suggest that the recent slowdown bottomed in the second quarter of 2024. This is a good environment for active stockpickers, with the median small-cap manager outperforming in every economic recovery over the last 20 years (with an average return of 37% versus the ASX 100's 20% in these nine instances (see below).And yet, despite the stellar run in small-cap stocks over the last 12 months, the ASX Small Ordinaries Index remains cheap. That's according to Firetrail's small-cap team, who believe the index is currently offering up the \"cheapest growth in the world\".","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/18-stocks-backed-by-a-fund-that-returned-42-in-12-months","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/18-stocks-backed-by-a-fund-that-returned-42-in-12-months","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7095","BK7110","BK7511","XKO.AU","BK7506","BK7113","IDX.AU","BK7089","BK7041","BK7153","BK7104","FFM.AU","NEU.AU","QOR.AU","AEL.AU","MYR.AU","GMD.AU","NXG.AU","WC8.AU","CAJ.AU","XJO.AU","BK7054","BK7008","BK7083","PMV.AU","BK7016","GDG.AU","BK7067","XAO.AU","PYC.AU","HUB.AU","BK7507","SFR.AU","BK7021","BK7024","BK7508","A1M.AU","NWL.AU","BK7062","BK7096","360.AU","REG.AU","BK7124","WES.AU","WHC.AU","BLX.AU","BK7029"],"gpt_icon":0},{"id":"2483333159","title":"New Forecasts: Here's What Analysts Think The Future Holds For Neuren Pharmaceuticals Limited (ASX:NEU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483333159","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483333159?lang=en_us&edition=fundamental","pubTime":"2024-11-15 04:00","pubTimestamp":1731614419,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals Limited  shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus estimated revenue numbers rose, with their view now clearly much more bullish on the company's business prospects. Neuren Pharmaceuticals has also found favour with investors, with the stock up a noteworthy 20% to AU$17.30 over the past week. Could this upgrade be enough to drive the stock even higher?Following the latest upgrade, the current consensus, from the six analysts covering Neuren Pharmaceuticals, is for revenues of AU$163m in 2024, which would reflect a considerable 16% reduction in Neuren Pharmaceuticals' sales over the past 12 months. Before the latest update, the analysts were foreseeing AU$123m of revenue in 2024. The consensus has definitely become more optimistic, showing a very substantial lift in revenue forecasts.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/forecasts-heres-analysts-think-future-200019637.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4109","NEU.AU","BK7508","BK7096","NEU"],"gpt_icon":1},{"id":"2483419353","title":"Here are the best-performing ASX 200 shares since the US election result","url":"https://stock-news.laohu8.com/highlight/detail?id=2483419353","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483419353?lang=en_us&edition=fundamental","pubTime":"2024-11-15 04:00","pubTimestamp":1731614400,"startTime":"0","endTime":"0","summary":"Maybe, maybe not.  Zip has been on a tear all year, up 434% in 2024 alone and up 7.64% since the US election.  Zip has a substantial US business that delivered \"outstanding growth\" in FY24, according to CEO Cynthia Scott.  What are Trump's economic policies?In a recent article, Betashares Senior Investment Strategist Cameron Gleeson provided this handy summary of Trump's economic policies below.  This will provide some clues on how the companies you are invested in might be impacted. Taxes and spending  Cut corporate tax rate from 21% to 15% Increase taxes on buybacks and companies'","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/15/here-are-the-best-performing-asx-200-shares-since-the-us-election-result/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7043","LU0267386448.USD","BK7033","JLG.AU","AMP.AU","LU1989772840.SGD","BK7044","BK7096","MP1.AU","BK7095","BK4554","HMC.AU","LU0225283273.USD","LU1720051108.HKD","NEU.AU","BK4585","BK7158","BK4551","BK4528","LU1162221912.USD","BK7112","IE00B19Z3B42.SGD","BK4106","BK4588","BK4127","LU0320765646.SGD","LU1720051017.SGD","IE00BKVL7J92.USD","LU0006306889.USD","SQ2.AU","IE00BZ1G4Q59.USD","BK7504","ZIP.AU","BK7005","JHX.AU","LU0106831901.USD","LU0314104364.USD","XJO.AU","LTR.AU","CTD.AU","IE00BHPRN162.USD","LU1861559042.SGD","BK7103","BK4516","LU0971096721.USD","SIG.AU","IE00B7SZLL34.SGD","LU1074936037.SGD"],"gpt_icon":1},{"id":"2483484957","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2483484957","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483484957?lang=en_us&edition=fundamental","pubTime":"2024-11-14 13:59","pubTimestamp":1731563994,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index (ASX: XJO) managed to snap the three-day losing streak it had been on this week to push higher today. After falling all week, ASX investors appeared to decide enough was enough t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/14/here-are-the-top-10-asx-200-shares-today-532/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7096","BK7070","NEU.AU","BK7044","TAH.AU","XJO.AU","BK7012","BK7020","BK7078","BK7503","XRO.AU","CWY.AU","FLT.AU","JHX.AU","RWC.AU","NUF.AU","WEB.AU","BK7016","CTD.AU","BK7047","BK7508"],"gpt_icon":1},{"id":"2483689331","title":"Neuren Pharmaceuticals to Launch AU$50 Million Share Buyback; Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483689331","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483689331?lang=en_us&edition=fundamental","pubTime":"2024-11-14 10:08","pubTimestamp":1731550114,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  plans to launch a share buyback program of up to 3 million shares worth AU$50 million for up to 12 months, according to a Thursday filing with the Australian bourse.The shares to be acquired represent 2.4% of the company's total shares in issue.The capital deployment comes as the company is poised to receive one-third of the proceeds from the sale of Neuren licensee Acadia Pharmaceuticals' Rare Pediatric Disease Priority Review Voucher for $150 million, the filing said.The pharmaceutical company's shares were up more than 5% in recent Thursday trade.Price : $17.44, Change: $+0.90, Percent Change: +5.44%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1043141123.HKD","LU0994945656.USD","BK7508","LU0426417589.USD","BK4125","AUD","LU0345774631.USD","LU0426412945.USD","LU2238339852.HKD","NEU.AU","BK7096"],"gpt_icon":0},{"id":"2483860830","title":"3 ASX healthcare shares going gangbusters on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2483860830","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483860830?lang=en_us&edition=fundamental","pubTime":"2024-11-14 09:00","pubTimestamp":1731546012,"startTime":"0","endTime":"0","summary":"Three ASX healthcare shares are making their shareholders very happy today, posting gains of 5%, 12% and 19% respectively in morning trade. And this strong performance comes despite some broader healthcare sector headwinds on Thursday, which sees the S&P/ASX 200 Health Care Index  down 0.4% at this same time. So, which three ASX healthcare shares are bucking the trend and flying higher?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/14/3-asx-healthcare-shares-going-gangbusters-on-thursday/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK7067","BK7508","IMM.AU","BK7096","MSB.AU","NEU.AU"],"gpt_icon":1},{"id":"2483645668","title":"BUZZ-Australia's Neuren Pharma hits over 3-month high on $32 mln share buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2483645668","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483645668?lang=en_us&edition=fundamental","pubTime":"2024-11-14 07:47","pubTimestamp":1731541644,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Neuren Pharma hits over 3-month high on $32 mln share buyback ** Shares of Neuren Pharmaceuticals NEU.AX rise as much as 8.4% to A$17.940, their highest since Aug. 5** Stock biggest pct gainer on the benchmark S&P/ASX 200 index .AXJO ** Drug manufacturer announces commencement of on-market share buyback programme of up to A$50 mln ** Says will buy up to 3 mln shares at A$16.540 per share, based on the last close of Wednesday** Stock down 33.8% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4N3MK2A2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEU.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2483940866","title":"BRIEF-Neuren Pharmaceuticals Announces A$50M On-Market Share Buy-Back Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2483940866","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483940866?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:14","pubTimestamp":1731536090,"startTime":"0","endTime":"0","summary":"BRIEF-Neuren Pharmaceuticals Announces A$50M On-Market Share Buy-Back ProgramNov 14 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX:ANNOUNCES A$50M ON-MARKET SHARE BUY-BACK PROGRAMFurther company coverage: NEU.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK340:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","NEU.AU"],"gpt_icon":0},{"id":"2483986698","title":"Neuren Pharmaceuticals Ltd - Announces a$50M on-Market Share Buy-Back Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2483986698","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483986698?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:14","pubTimestamp":1731536056,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK340:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","NEU.AU","BK7096"],"gpt_icon":0},{"id":"2482371627","title":"Why ANZ, Block, Neuren, and Pilbara Minerals shares are pushing higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2482371627","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482371627?lang=en_us&edition=fundamental","pubTime":"2024-11-12 10:29","pubTimestamp":1731378582,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index(ASX: XJO) is on course to record another decline. At the time of writing, the benchmark index is down 0.5% to 8,223.4 points. Four ASX shares that are not lett","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/12/why-anz-block-neuren-and-pilbara-minerals-shares-are-pushing-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PLS.AU","IE00B19Z3581.USD","IE00BHPRN162.USD","BK7095","BK7135","BK4585","BK7507","BK7511","SQ2.AU","BK4581","IE00B19Z3B42.SGD","BK4109","BK4554","LU1861559042.SGD","BK7096","BK7033","BK7508","LU1861558580.USD","BK7504","MTX","XJO.AU","IE0002270589.USD","ANZ.AU","BK4551","BK4503","BK4106","BK4528","NEU.AU","BK7158","BK4227","IE00B7SZLL34.SGD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":97,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEU.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740697200000,"name":null,"time":"","dateTimestamp":1740661200000,"actualEps":null},{"market":"AU","date":"2024-02-29","symbol":"NEU.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1709125200000,"reportTimeType":"","actualEps":null},{"date":"2023-08-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":[]}}